MedTrace Logo

ToT and Estrogen in Postmenopausal Females

NCT03295487 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2022-10-25

No results posted yet for this study

Summary

To compare the subjective and objective outcomes of TVT-O procedure alone versus the same procedure followed by the use of premarin vaginal cream for 3 months in postmenopausal female with genuine stress incontinence.

Conditions

  • Stress Urinary Incontinence
  • Postmenopausal Disorder

Interventions

PROCEDURE

TVT-O

transobturator tape has been applied to all the patients in the study,and local estrogen vaginal cream is only applied to patients in group A

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
49 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295487 on ClinicalTrials.gov